U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C31H39N5O5
Molecular Weight 561.6719
Optical Activity UNSPECIFIED
Defined Stereocenters 6 / 6
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Ergocornine

SMILES

CC(C)[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4CC5=CNC6=C5C(=CC=C6)C4=C3)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C

InChI

InChIKey=UJYGDMFEEDNVBF-OGGGUQDZSA-N
InChI=1S/C31H39N5O5/c1-16(2)26-28(38)35-11-7-10-24(35)31(40)36(26)29(39)30(41-31,17(3)4)33-27(37)19-12-21-20-8-6-9-22-25(20)18(14-32-22)13-23(21)34(5)15-19/h6,8-9,12,14,16-17,19,23-24,26,32,40H,7,10-11,13,15H2,1-5H3,(H,33,37)/t19-,23-,24+,26+,30-,31+/m1/s1

HIDE SMILES / InChI

Molecular Formula C31H39N5O5
Molecular Weight 561.6719
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 6 / 6
E/Z Centers 0
Optical Activity UNSPECIFIED

Ergocornine is an ergot alkaloid. Ergocornine can inhibit prolactin release by a direct action on the anterior pituitary. It can modulate activity at both dopamine and serotonin receptors.

Originator

Sources: Stoll, A. & Hoffman, A. (1943). Helv. chim. Acta, 26, 1570.
Curator's Comment: reference retrieved from: http://onlinelibrary.wiley.com/doi/10.1113/jphysiol.1951.sp004529/pdf | https://books.google.com/books?id=MI544i8UdzUC&printsec=frontcover&hl=ru#v=onepage&q&f=false | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1637017/

Approval Year

PubMed

PubMed

TitleDatePubMed
Contractile response of fescue-naive bovine lateral saphenous veins to increasing concentrations of tall fescue alkaloids.
2010-01
Toxicity of endophyte-infected tall fescue alkaloids and grass metabolites on Pratylenchus scribneri.
2009-12
Development and validation of an LC-MS method for quantitation of ergot alkaloids in lateral saphenous vein tissue.
2009-08-26
A basic tool for risk assessment: a new method for the analysis of ergot alkaloids in rye and selected rye products.
2009-04
Determination of ergot alkaloids: purity and stability assessment of standards and optimization of extraction conditions for cereal samples.
2009-02-11
Recognition properties and competitive assays of a dual dopamine/serotonin selective molecularly imprinted polymer.
2008-12
Bromocriptine, a dopamine D(2) receptor agonist with the structure of the amino acid ergot alkaloids, induces neurite outgrowth in PC12 cells.
2008-11-19
Simultaneous determination of six major ergot alkaloids and their epimers in cereals and foodstuffs by LC-MS-MS.
2008-05
LC-MS/MS multi-method for mycotoxins after single extraction, with validation data for peanut, pistachio, wheat, maize, cornflakes, raisins and figs.
2008-04
Ergot alkaloids in rye flour determined by solid-phase cation-exchange and high-pressure liquid chromatography with fluorescence detection.
2008-03
A comparative study of topical natural ergot alkaloids on the intraocular pressure and aqueous humor dynamics in oclular normotensive and alpha-chymotrypsin-induced ocular hypertensive rabbits.
2007-10
Ergot alkaloids in Norwegian wild grasses: a mass spectrometric approach.
2007
Pharmacological characterization of the ergot alkaloid receptor in the salivary gland of the ixodid tick Amblyomma hebraeum.
2006-07
Quantitative determination of five ergot alkaloids in rye flour by liquid chromatography-electrospray ionisation tandem mass spectrometry.
2006-05-05
Mass spectral characterization of ergot alkaloids by electrospray ionization, hydrogen/deuterium exchange, and multiple stage mass spectrometry: Usefulness of precursor ion scan experiments.
2006
The influence of ergot-contaminated feed on growth and slaughtering performance, nutrient digestibility and carry over of ergot alkaloids in growing-finishing pigs.
2005-12
Electrospray[+] tandem quadrupole mass spectrometry in the elucidation of ergot alkaloids chromatographed by HPLC: screening of grass or forage samples for novel toxic compounds.
2005-11
Fragmentation patterns of selected ergot alkaloids by electrospray ionization tandem quadrupole mass spectrometry.
2004-11
Luteal 3beta-hydroxysteroid dehydrogenase and 20alpha-hydroxysteroid dehydrogenase activities in the rat corpus luteum of pseudopregnancy: effect of the deciduoma reaction.
2004-05-12
The effect of topical natural ergot alkaloids on the intraocular pressure and aqueous humor dynamics in rabbits with alpha-chymotrypsin-induced ocular hypertension.
2002-04
Effects of topical natural ergot alkaloids on intraocular pressure and aqueous humor dynamics in ocular normotensive rabbits.
2002-02
Semiquantitative determination of ergot alkaloids in seed, straw, and digesta samples using a competitive enzyme-linked immunosorbent assay.
2001-05
Clinical studies on the action of ergocornine in women.
1966-12
Patents

Patents

Sample Use Guides

4 different ways of ergocornine administration: 2, 8, 10 mg for 5 days and 20 mg for 10 days. Each of these treatments started from the second day of high temperature phase.
Route of Administration: Oral
In Vitro Use Guide
Curator's Comment: Ergocornine induced neurite outgrowth in PC12 cells
Unknown
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:56:06 GMT 2025
Edited
by admin
on Mon Mar 31 19:56:06 GMT 2025
Record UNII
7W36B25464
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NSC-407316
Preferred Name English
Ergocornine
MI  
Common Name English
Ergocornin
Common Name English
(5??)-12?-Hydroxy-2?,5?-bis(1-methylethyl)ergotaman-3?,6?,18-trione
Systematic Name English
Ergotaman-3?,6?,18-trione, 12?-hydroxy-2?,5?-bis(1-methylethyl)-, (5??)-
Systematic Name English
ERGOCORNINE [MI]
Common Name English
Code System Code Type Description
PUBCHEM
73453
Created by admin on Mon Mar 31 19:56:06 GMT 2025 , Edited by admin on Mon Mar 31 19:56:06 GMT 2025
PRIMARY
WIKIPEDIA
ERGOCORNINE
Created by admin on Mon Mar 31 19:56:06 GMT 2025 , Edited by admin on Mon Mar 31 19:56:06 GMT 2025
PRIMARY
CAS
564-36-3
Created by admin on Mon Mar 31 19:56:06 GMT 2025 , Edited by admin on Mon Mar 31 19:56:06 GMT 2025
PRIMARY
ECHA (EC/EINECS)
209-272-7
Created by admin on Mon Mar 31 19:56:06 GMT 2025 , Edited by admin on Mon Mar 31 19:56:06 GMT 2025
PRIMARY
MERCK INDEX
m4975
Created by admin on Mon Mar 31 19:56:06 GMT 2025 , Edited by admin on Mon Mar 31 19:56:06 GMT 2025
PRIMARY Merck Index
EPA CompTox
DTXSID40971841
Created by admin on Mon Mar 31 19:56:06 GMT 2025 , Edited by admin on Mon Mar 31 19:56:06 GMT 2025
PRIMARY
FDA UNII
7W36B25464
Created by admin on Mon Mar 31 19:56:06 GMT 2025 , Edited by admin on Mon Mar 31 19:56:06 GMT 2025
PRIMARY
NSC
407316
Created by admin on Mon Mar 31 19:56:06 GMT 2025 , Edited by admin on Mon Mar 31 19:56:06 GMT 2025
PRIMARY
CHEBI
4820
Created by admin on Mon Mar 31 19:56:06 GMT 2025 , Edited by admin on Mon Mar 31 19:56:06 GMT 2025
PRIMARY